Imunon Inc (IMNN)
1.30
-0.01
(-0.76%)
USD |
NASDAQ |
May 07, 16:00
1.30
0.00 (0.00%)
After-Hours: 20:00
Imunon Cash from Operations (Quarterly): -3.772M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -3.772M |
September 30, 2023 | -4.472M |
June 30, 2023 | -6.692M |
March 31, 2023 | -4.086M |
December 31, 2022 | -5.008M |
September 30, 2022 | -4.640M |
June 30, 2022 | -5.473M |
March 31, 2022 | -7.976M |
December 31, 2021 | -5.088M |
September 30, 2021 | -3.786M |
June 30, 2021 | -2.612M |
March 31, 2021 | -4.737M |
December 31, 2020 | -3.732M |
September 30, 2020 | -3.964M |
June 30, 2020 | -2.948M |
March 31, 2020 | -4.975M |
December 31, 2019 | -5.617M |
September 30, 2019 | -4.480M |
June 30, 2019 | -4.626M |
March 31, 2019 | -5.536M |
December 31, 2018 | 6.086M |
September 30, 2018 | -4.266M |
June 30, 2018 | -4.207M |
March 31, 2018 | -4.655M |
December 31, 2017 | -4.209M |
Date | Value |
---|---|
September 30, 2017 | -5.107M |
June 30, 2017 | -4.196M |
March 31, 2017 | -3.13M |
December 31, 2016 | -4.663M |
September 30, 2016 | -4.722M |
June 30, 2016 | -4.250M |
March 31, 2016 | -4.744M |
December 31, 2015 | -3.899M |
September 30, 2015 | -5.321M |
June 30, 2015 | -5.674M |
March 31, 2015 | -5.936M |
December 31, 2014 | -6.510M |
September 30, 2014 | -5.837M |
June 30, 2014 | -4.183M |
March 31, 2014 | -4.823M |
December 31, 2013 | -3.466M |
September 30, 2013 | -2.662M |
June 30, 2013 | -5.187M |
March 31, 2013 | 1.790M |
December 31, 2012 | -5.978M |
September 30, 2012 | -5.254M |
June 30, 2012 | -5.184M |
March 31, 2012 | -5.728M |
December 31, 2011 | -4.440M |
September 30, 2011 | -6.905M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-7.976M
Minimum
Mar 2022
-2.612M
Maximum
Jun 2021
-4.668M
Average
-4.626M
Median
Jun 2019
Cash from Operations (Quarterly) Benchmarks
Avalo Therapeutics Inc | -2.766M |
iBio Inc | -4.706M |
Ocugen Inc | -11.30M |
Petros Pharmaceuticals Inc | -2.260M |
Moderna Inc | -989.00M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -3.304M |
Cash from Financing (Quarterly) | 0.0302M |
Free Cash Flow | -19.47M |
Free Cash Flow Per Share (Quarterly) | -0.4012 |
Free Cash Flow Yield | -165.5% |